NCT04637763 · Interventional trial
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
Overall registry status Active not recruiting
Phase 1
Conditions B Cell Lymphoma, B Cell Non-Hodgkin's Lymphoma, Lymphoma, Lymphoma, Non-Hodgkin, Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory